All cancer immunotherapty articles
-
NewsOncolytic viruses and CAR cells team up against solid tumors
Oncolytic viruses and CAR-T or CAR-NK cells could be engineered together to overcome some of the biggest barriers in solid tumor treatment. A new review outlines how these therapies may be combined into programmable systems that improve tumor targeting, immune-cell infiltration and sustained antitumor activity.